Adoptive T-cell immunotherapy using T-cell receptor gene transfer: aiming at a cure for cancer. 2011

Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D015316 Genetic Therapy Techniques and strategies which include the use of coding sequences and other conventional or radical means to transform or modify cells for the purpose of treating or reversing disease conditions. Gene Therapy,Somatic Gene Therapy,DNA Therapy,Gene Therapy, Somatic,Genetic Therapy, Gametic,Genetic Therapy, Somatic,Therapy, DNA,Therapy, Gene,Therapy, Somatic Gene,Gametic Genetic Therapies,Gametic Genetic Therapy,Genetic Therapies,Genetic Therapies, Gametic,Genetic Therapies, Somatic,Somatic Genetic Therapies,Somatic Genetic Therapy,Therapies, Gametic Genetic,Therapies, Genetic,Therapies, Somatic Genetic,Therapy, Gametic Genetic,Therapy, Genetic,Therapy, Somatic Genetic
D016219 Immunotherapy, Adoptive Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314) Adoptive Cellular Immunotherapy,Adoptive Immunotherapy,CAR T-Cell Therapy,Cellular Immunotherapy, Adoptive,Chimeric Antigen Receptor Therapy,Immunotherapy, Adoptive Cellular,Adoptive Cellular Immunotherapies,Adoptive Immunotherapies,CAR T Cell Therapy,CAR T-Cell Therapies,Cellular Immunotherapies, Adoptive,Immunotherapies, Adoptive,Immunotherapies, Adoptive Cellular,T-Cell Therapies, CAR,T-Cell Therapy, CAR,Therapies, CAR T-Cell,Therapy, CAR T-Cell
D019672 Genes, T-Cell Receptor DNA sequences, in cells of the T-lymphocyte lineage, that code for T-cell receptors. The TcR genes are formed by somatic rearrangement (see GENE REARRANGEMENT, T-LYMPHOCYTE and its children) of germline gene segments, and resemble Ig genes in their mechanisms of diversity generation and expression. T-Cell Receptor Genes,TcR Genes,Gene, T-Cell Receptor,Gene, TcR,Genes, T Cell Receptor,Genes, TcR,T Cell Receptor Genes,T-Cell Receptor Gene,TcR Gene

Related Publications

Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara
April 2011, Self/nonself,
Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara
June 2006, Immunology and cell biology,
Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara
December 2009, Cancer research,
Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara
January 2015, Rambam Maimonides medical journal,
Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara
June 2010, Archivum immunologiae et therapiae experimentalis,
Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara
June 2014, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara
November 2006, Human gene therapy,
Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara
September 2020, Scandinavian journal of immunology,
Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara
June 1999, Cytokines, cellular & molecular therapy,
Masaki Yasukawa, and Toshiki Ochi, and Hiroshi Fujiwara
February 2020, Journal of immunotherapy and precision oncology,
Copied contents to your clipboard!